High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease

被引:36
|
作者
Jayakumari, Narayani [1 ]
Thejaseebai, Gopalan [1 ]
机构
[1] Sree Chitra Tirunal Inst Med Sci & Technol, Div Biochem, Thiruvananthapuram 695011, Kerala, India
关键词
Atherosclerosis; Paraoxonase; HDL; Oxidativestress; LOW-DENSITY-LIPOPROTEIN; DIABETES-MELLITUS; ATHEROSCLEROSIS; MICE; POLYMORPHISM; OXIDATION; LDL;
D O I
10.3164/jcbn.08-255
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Paraoxonase-1 (PON-1), an HDL-associated enzyme has been shown to possess antioxidant/anti-inflammatory properties and protect against atherogenesis. The aim of the study was to explore the association of PON-1, with lipids, antioxidant-vitamins and lifestyle in male subjects with and without angiographically documented coronary artery disease (CAD) and in healthy volunteers. PON-1 activity was measured spectrophotometrically using phenyl acetate as substrate. PON-1 and HDL-Cholesterol were significantly lower and lipid peroxides and triglycerides were higher in CAD patients than in normal coronary and control subjects. PON-1 activity showed positive association with HDL-C and inverse relation with lipid peroxides and no association with antioxidant vitamins in healthy subjects. Smoking habit, alcohol intake and diabetes mellitus did not seem to influence PON-1 activity. Serum levels of PON-1 and HDL-C showed inverse association with the presence of CAD but are not related to the severity of disease in terms of number of diseased vessels. Interventional means by diet/drugs to enhance PON-1 activity may contribute to attenuation of atherosclerosis.
引用
收藏
页码:278 / 284
页数:7
相关论文
共 50 条
  • [21] Paraoxonase-1 and cardiovascular disease
    Mackness, B.
    Mackness, M. L.
    PARAOXNASES: THEIR ROLE IN DISEASE DEVELOPMENT AND XENOBIOTIC METABOLISM, 2008, 6 : 51 - 60
  • [22] Paraoxonase-1 and Coronary Heart Diseases
    Tarcin, Ozlem
    MARMARA MEDICAL JOURNAL, 2011, 24 (01): : 59 - 63
  • [23] Purification of Human Serum Paraoxonase-1
    Naik, R. Redya
    Sankarshana, T.
    INTERNATIONAL JOURNAL OF ADVANCED BIOTECHNOLOGY AND RESEARCH, 2015, 6 (01): : 80 - 85
  • [24] Paraoxonase gene polymorphism and coronary artery disease in Indian subjects
    Pati, N
    Pati, U
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 66 (02) : 165 - 168
  • [25] Association between paraoxonase-1 gene promoter T (407) C polymorphism and coronary artery disease
    Najafi, M.
    Gohari, L. Hosseini
    Firoozrai, M.
    Zavarehee, A.
    Basiri, H. A.
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2008, 37 (01) : 108 - 113
  • [26] Paraoxonase-1 Phenotype and Its Relationship with Mean Platelet Volume and Oxidative Stress in Coronary Artery Disease
    Selek, Sahabettin
    Ozer, Omer Faruk
    Goktekin, Omer
    Kocyigit, Abdurrahim
    Kalinbacoglu, Ceren
    Islek, Irem
    Islek, Tugba
    Arpaci, Beyza
    Erol, Neval
    Meydan, Sedat
    Guler, Eray Metin
    BEZMIALEM SCIENCE, 2015, 3 (02): : 24 - 28
  • [27] Trace Elements and Paraoxonase-1 Activity in Lower Extremity Artery Disease
    Rovira, Joaquim
    Hernandez-Aguilera, Anna
    Luciano-Mateo, Fedra
    Cabre, Noemi
    Baiges-Gaya, Gerard
    Nadal, Marti
    Martin-Paredero, Vicente
    Camps, Jordi
    Joven, Jorge
    Domingo, Jose L.
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2018, 186 (01) : 74 - 84
  • [28] Circulating activity of secretory phospholipase A2 and paraoxonase-1 in relation to the severity of coronary artery disease
    Basati, Gholam
    Naderi, Gholam Ali
    Boshtam, Maryam
    Razavi, Amir Nader Emami
    Sadeghi, Masoumeh
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S46 - S46
  • [29] Trace Elements and Paraoxonase-1 Activity in Lower Extremity Artery Disease
    Joaquim Rovira
    Anna Hernández-Aguilera
    Fedra Luciano-Mateo
    Noemí Cabré
    Gerard Baiges-Gaya
    Martí Nadal
    Vicente Martín-Paredero
    Jordi Camps
    Jorge Joven
    José L. Domingo
    Biological Trace Element Research, 2018, 186 : 74 - 84
  • [30] HIGH PARAOXONASE-1 HDL IS MORE EFFECTIVE THAN LOW PARAOXONASE-1 HDL IN IMPEDING LDL OXIDATION IN VITRO
    Hama, S.
    Soran, H.
    Albeck, S.
    Charlton-Menys, V.
    Yadav, R.
    Liu, Y.
    France, M.
    Tawfiq, D.
    Durrington, P.
    ATHEROSCLEROSIS, 2012, 223 (02) : 529 - 529